News The Post-Pandemic World of Antibiotics COVID-19 Antibiotics are cheap and common drugs used to treat bacterial infections.
Partner Content Partner Content Q&A with Team Consulting Ltd released for Injectable Drug De... Q&A with Team Consulting released for Injectable Drug
Events Partner Content SMi’s Inaugural Conference: Respiratory Drug Delivery 2019 Respiratory Drug Delivery Conference 2019
Partner Content Partner Content Explore New Strategies to Maintain a Global Pharmacovigilanc... Drug Safety Conference London 2018
Partner Content Partner Content Explore New Strategies to Maintain a Global Pharmacovigilanc... Drug Safety 2018
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
